TheraB, a life sciences spin-out of Michigan State University, has received $150,000 in pre-seed funding to boost the fresh startup’s efforts to tackle infant jaundice.
The funding, which came via medtech early-stage investor Quantum Medical Concepts, will be used to advance product development.
The US-based spin-out is developing the Snuglit portable phototherapy blanket, which provides the blue light newborn require to breakdown bilburin molecules, a blood pigment which causes jaundice.
Ryan Jankovic, CEO of TheraB, said: “We’ve worked to make…
